{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:06:11Z","timestamp":1772136371195,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-79013-x","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T01:12:21Z","timestamp":1731373941000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Inserting Omp22 into the flagellin protein, replacing its hypervariable region, results in stronger protection against lethal Acinetobacter baumannii infection"],"prefix":"10.1038","volume":"14","author":[{"given":"Bahador","family":"Behrouz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iraj","family":"Rasooli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farzad","family":"Badmasti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,12]]},"reference":[{"key":"79013_CR1","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.3389\/fmicb.2019.01601","volume":"10","author":"FC Morris","year":"2019","unstructured":"Morris, F. C., Dexter, C., Kostoulias, X., Uddin, M. I. & Peleg, A. Y. The mechanisms of Disease caused by Acinetobacter baumannii. Front. Microbiol. 10, 1601. https:\/\/doi.org\/10.3389\/fmicb.2019.01601 (2019).","journal-title":"Front. Microbiol."},{"key":"79013_CR2","doi-asserted-by":"publisher","first-page":"2289769","DOI":"10.1080\/21505594.2023.2289769","volume":"15","author":"M Lucidi","year":"2024","unstructured":"Lucidi, M. et al. Pathogenicity and virulence of Acinetobacter baumannii: factors contributing to the fitness in healthcare settings and the infected host. Virulence. 15, 2289769. https:\/\/doi.org\/10.1080\/21505594.2023.2289769 (2024).","journal-title":"Virulence"},{"key":"79013_CR3","doi-asserted-by":"publisher","first-page":"1332108","DOI":"10.3389\/fmicb.2024.1332108","volume":"15","author":"J Shi","year":"2024","unstructured":"Shi, J., Cheng, J., Liu, S., Zhu, Y. & Zhu, M. Acinetobacter baumannii: an evolving and cunning opponent. Front. Microbiol. 15, 1332108. https:\/\/doi.org\/10.3389\/fmicb.2024.1332108 (2024).","journal-title":"Front. Microbiol."},{"key":"79013_CR4","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1097\/ccm.0000000000004371","volume":"48","author":"SS Kadri","year":"2020","unstructured":"Kadri, S. S. Key takeaways from the U.S. CDC\u2019s 2019 Antibiotic Resistance threats Report for Frontline providers. Crit. Care Med. 48, 939\u2013945. https:\/\/doi.org\/10.1097\/ccm.0000000000004371 (2020).","journal-title":"Crit. Care Med."},{"key":"79013_CR5","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"CJL Murray","year":"2022","unstructured":"Murray, C. J. L. et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 399, 629\u2013655. https:\/\/doi.org\/10.1016\/S0140-6736(21)02724-0 (2022).","journal-title":"Lancet"},{"key":"79013_CR6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s15010-021-01643-4","volume":"50","author":"A Russo","year":"2022","unstructured":"Russo, A. et al. Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit. Infection. 50, 83\u201392 (2022).","journal-title":"Infection"},{"key":"79013_CR7","doi-asserted-by":"publisher","first-page":"20724","DOI":"10.1038\/srep20724","volume":"6","author":"W Huang","year":"2016","unstructured":"Huang, W. et al. Immunization with a 22-kDa outer membrane protein elicits protective immunity to multidrug-resistant Acinetobacter baumannii. Sci. Rep. 6, 20724. https:\/\/doi.org\/10.1038\/srep20724 (2016).","journal-title":"Sci. Rep."},{"key":"79013_CR8","doi-asserted-by":"publisher","first-page":"5436","DOI":"10.1016\/j.vaccine.2020.06.052","volume":"38","author":"F Ramezanalizadeh","year":"2020","unstructured":"Ramezanalizadeh, F., Owlia, P. & Rasooli, I. Type I pili, CsuA\/B and FimA induce a protective immune response against Acinetobacter baumannii. Vaccine. 38, 5436\u20135446. https:\/\/doi.org\/10.1016\/j.vaccine.2020.06.052 (2020).","journal-title":"Vaccine"},{"key":"79013_CR9","doi-asserted-by":"publisher","unstructured":"Jahangiri, A. et al. Specific egg yolk immunoglobulin as a promising non-antibiotic biotherapeutic product against Acinetobacter baumannii pneumonia infection. Sci Rep 11, doi: (1914). https:\/\/doi.org\/10.1038\/s41598-021-81356-8 (2021).","DOI":"10.1038\/s41598-021-81356-8"},{"key":"79013_CR10","doi-asserted-by":"publisher","first-page":"110650","DOI":"10.1016\/j.intimp.2023.110650","volume":"122","author":"M Mansouri","year":"2023","unstructured":"Mansouri, M. et al. Synergistic immunoprotection by Oma87 and Bap against Acinetobacter baumannii sepsis model. Int. Immunopharmacol. 122, 110650. https:\/\/doi.org\/10.1016\/j.intimp.2023.110650 (2023).","journal-title":"Int. Immunopharmacol."},{"key":"79013_CR11","doi-asserted-by":"publisher","unstructured":"Lau, Y. T. & Tan, H. S. Acinetobacter baumannii subunit vaccines: recent progress and challenges. Crit. Rev. Microbiol. 1\u201316. https:\/\/doi.org\/10.1080\/1040841X.2023.2215303 (2023).","DOI":"10.1080\/1040841X.2023.2215303"},{"key":"79013_CR12","doi-asserted-by":"publisher","first-page":"1088130","DOI":"10.3389\/fimmu.2022.1088130","volume":"13","author":"N Yang","year":"2022","unstructured":"Yang, N. et al. Subunit vaccines for Acinetobacter baumannii. Front. Immunol. 13, 1088130. https:\/\/doi.org\/10.3389\/fimmu.2022.1088130 (2022).","journal-title":"Front. Immunol."},{"key":"79013_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/sji.12769","volume":"90","author":"AQ Yang","year":"2019","unstructured":"Yang, A. Q., Yang, H. Y., Guo, S. J. & Xie, Y. E. MF59 adjuvant enhances the immunogenicity and protective immunity of the OmpK\/Omp22 fusion protein from Acineterbacter Baumannii through intratracheal inoculation in mice. Scand. J. Immunol. 90, 9. https:\/\/doi.org\/10.1111\/sji.12769 (2019).","journal-title":"Scand. J. Immunol."},{"key":"79013_CR14","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.2147\/IJN.S296527","volume":"16","author":"X Du","year":"2021","unstructured":"Du, X. et al. A multiepitope peptide, rOmp22, encapsulated in Chitosan-PLGA nanoparticles as a candidate vaccine against Acinetobacter baumannii infection. Int. J. Nanomed. 16, 1819\u20131836. https:\/\/https:\/\/doi.org\/10.2147%2FIJN.S296527 (2021).","journal-title":"Int. J. Nanomed."},{"key":"79013_CR15","doi-asserted-by":"publisher","first-page":"123961","DOI":"10.1016\/j.ijpharm.2024.123961","volume":"654","author":"S Sabzi","year":"2024","unstructured":"Sabzi, S. et al. Polydopamine-based nano adjuvant as a promising vaccine carrier induces significant immune responses against Acinetobacter baumannii-associated pneumonia. Int. J. Pharm. 654, 123961. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.123961 (2024).","journal-title":"Int. J. Pharm."},{"key":"79013_CR16","doi-asserted-by":"publisher","unstructured":"Huang, W. et al. Employing Escherichia coli-derived outer membrane vesicles as an antigen delivery platform elicits protective immunity against Acinetobacter baumannii infection. Sci. Rep. 6 https:\/\/doi.org\/10.1038\/srep37242 (2016).","DOI":"10.1038\/srep37242"},{"key":"79013_CR17","doi-asserted-by":"publisher","first-page":"e373","DOI":"10.1038\/emm.2017.172","volume":"49","author":"IA Hajam","year":"2017","unstructured":"Hajam, I. A., Dar, P. A., Shahnawaz, I., Jaume, J. C. & Lee, J. H. Bacterial flagellin\u2014a potent immunomodulatory agent. Exp. Mol. Med. 49, e373\u2013e373. https:\/\/doi.org\/10.1038\/emm.2017.172 (2017).","journal-title":"Exp. Mol. Med."},{"key":"79013_CR18","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/14760584.2018.1457443","volume":"17","author":"B Cui","year":"2018","unstructured":"Cui, B. et al. Flagellin as a vaccine adjuvant. Expert Rev. Vaccines. 17, 335\u2013349. https:\/\/doi.org\/10.1080\/14760584.2018.1457443 (2018).","journal-title":"Expert Rev. Vaccines"},{"key":"79013_CR19","doi-asserted-by":"publisher","first-page":"101330","DOI":"10.1016\/j.coviro.2023.101330","volume":"60","author":"JH Rhee","year":"2023","unstructured":"Rhee, J. H., Khim, K., Puth, S., Choi, Y. & Lee, S. E. Deimmunization of flagellin adjuvant for clinical application. Curr. Opin. Virol. 60, 101330. https:\/\/doi.org\/10.1016\/j.coviro.2023.101330 (2023).","journal-title":"Curr. Opin. Virol."},{"key":"79013_CR20","doi-asserted-by":"publisher","first-page":"21872","DOI":"10.1021\/acsami.2c01028","volume":"14","author":"Y Zhao","year":"2022","unstructured":"Zhao, Y., Li, Z., Voyer, J., Li, Y. & Chen, X. Flagellin\/Virus-like particle hybrid platform with high immunogenicity, Safety, and versatility for Vaccine Development. ACS Appl. Mater. Interfaces. 14, 21872\u201321885. https:\/\/doi.org\/10.1021\/acsami.2c01028 (2022).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"79013_CR21","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1086\/517613","volume":"195","author":"WF McDonald","year":"2007","unstructured":"McDonald, W. F. et al. A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity. J. Infect. Dis. 195, 1607\u20131617. https:\/\/doi.org\/10.1086\/517613 (2007).","journal-title":"J. Infect. Dis."},{"key":"79013_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1128\/cvi.00333-08","volume":"16","author":"SB Mizel","year":"2009","unstructured":"Mizel, S. B. et al. Flagellin-F1-V fusion protein is an effective plague vaccine in mice and two species of nonhuman primates. Clin. Vaccine Immunol. 16, 21\u201328. https:\/\/doi.org\/10.1128\/cvi.00333-08 (2009).","journal-title":"Clin. Vaccine Immunol."},{"key":"79013_CR23","doi-asserted-by":"publisher","DOI":"10.1039\/d4nh00287c","author":"JK Kim","year":"2024","unstructured":"Kim, J. K. et al. Double-layered protein nanoparticles conjugated with truncated flagellin induce improved mucosal and systemic immune responses in mice. Nanoscale Horiz. https:\/\/doi.org\/10.1039\/d4nh00287c (2024).","journal-title":"Nanoscale Horiz"},{"key":"79013_CR24","doi-asserted-by":"publisher","first-page":"e1011520","DOI":"10.1371\/journal.ppat.1011520","volume":"19","author":"AK Cain","year":"2023","unstructured":"Cain, A. K. & Hamidian, M. Portrait of a killer: uncovering resistance mechanisms and global spread of Acinetobacter baumannii. PLoS Pathog. 19, e1011520. https:\/\/doi.org\/10.1371\/journal.ppat.1011520 (2023).","journal-title":"PLoS Pathog"},{"key":"79013_CR25","doi-asserted-by":"publisher","unstructured":"Hinkula, J., Nystrom, S., Devito, C., Brave, A. & Applequist, S. E. Long-lasting mucosal and systemic immunity against Influenza A Virus is significantly prolonged and protective by nasal whole influenza immunization with mucosal adjuvant N3 and DNA-Plasmid expressing flagellin in Aging In- and Outbred mice. Vaccines (Basel). 7. https:\/\/doi.org\/10.3390\/vaccines7030064 (2019).","DOI":"10.3390\/vaccines7030064"},{"key":"79013_CR26","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1021\/acs.bioconjchem.7b00320","volume":"29","author":"F Guo","year":"2018","unstructured":"Guo, F. et al. Prompt and robust humoral immunity elicited by a Conjugated Chimeric Malaria Antigen with a truncated flagellin. Bioconjug. Chem. 29, 761\u2013770. https:\/\/doi.org\/10.1021\/acs.bioconjchem.7b00320 (2018).","journal-title":"Bioconjug. Chem."},{"key":"79013_CR27","doi-asserted-by":"publisher","unstructured":"Stepanova, L. A. et al. Flagellin-fused protein targeting M2e and HA2 induces innate and T-Cell responses in mice of different genetic lines. Vaccines (Basel). 10. https:\/\/doi.org\/10.3390\/vaccines10122098 (2022).","DOI":"10.3390\/vaccines10122098"},{"key":"79013_CR28","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.4161\/hv.23809","volume":"9","author":"J Yang","year":"2013","unstructured":"Yang, J. et al. Antigen replacement of domains D2 and D3 in flagellin promotes mucosal IgA production and attenuates flagellin-induced inflammatory response after intranasal immunization. Hum. Vaccin Immunother. 9, 1084\u20131092. https:\/\/doi.org\/10.4161\/hv.23809 (2013).","journal-title":"Hum. Vaccin Immunother"},{"key":"79013_CR29","doi-asserted-by":"crossref","unstructured":"Ajamian, L., Melnychuk, L., Jean-Pierre, P. & Zaharatos, G. J. DNA Vaccine-Encoded Flagellin Can Be Used as an Adjuvant Scaffold to Augment HIV-1 gp41 Membrane Proximal External Region Immunogenicity. Viruses 10, doi: (2018). https:\/\/https:\/\/doi.org\/10.3390%2Fv10030100","DOI":"10.3390\/v10030100"},{"key":"79013_CR30","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.3389\/fimmu.2020.01069","volume":"11","author":"S Li","year":"2020","unstructured":"Li, S. et al. Development of different methods for preparing Acinetobacter baumannii outer membrane vesicles vaccine: impact of Preparation Method on Protective Efficacy. Front. Immunol. 11, 1069. https:\/\/doi.org\/10.3389\/fimmu.2020.01069 (2020).","journal-title":"Front. Immunol."},{"key":"79013_CR31","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1128\/iai.74.2.1113-1120.2006","volume":"74","author":"N Honko Anna","year":"2006","unstructured":"Honko Anna, N., Sriranganathan, N. & Lees Cynthia, J. Mizel Steven, B. Flagellin is an effective adjuvant for immunization against Lethal Respiratory Challenge with Yersinia pestis. Infect. Immun. 74, 1113\u20131120. https:\/\/doi.org\/10.1128\/iai.74.2.1113-1120.2006 (2006).","journal-title":"Infect. Immun."},{"key":"79013_CR32","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.virol.2017.06.001","volume":"509","author":"L Deng","year":"2017","unstructured":"Deng, L. et al. Protein nanoparticle vaccine based on flagellin carrier fused to influenza conserved epitopes confers full protection against influenza a virus challenge. Virology. 509, 82\u201389. https:\/\/doi.org\/10.1016\/j.virol.2017.06.001 (2017).","journal-title":"Virology"},{"key":"79013_CR33","doi-asserted-by":"publisher","first-page":"015","DOI":"10.1186\/s12896-015-0194-0","volume":"15","author":"KM Bennett","year":"2015","unstructured":"Bennett, K. M. et al. Hybrid flagellin as a T cell independent vaccine scaffold. BMC Biotechnol. 15, 015\u20130194. :https:\/\/https:\/\/doi.org\/10.1186%2Fs12896-015-0194-0 (2015).","journal-title":"BMC Biotechnol."},{"key":"79013_CR34","doi-asserted-by":"publisher","first-page":"5145","DOI":"10.1016\/j.vaccine.2011.05.041","volume":"29","author":"CB Turley","year":"2011","unstructured":"Turley, C. B. et al. Safety and immunogenicity of a recombinant M2e\u2013flagellin influenza vaccine (STF2.4xM2e) in healthy adults. Vaccine. 29, 5145\u20135152. https:\/\/doi.org\/10.1016\/j.vaccine.2011.05.041 (2011).","journal-title":"Vaccine"},{"key":"79013_CR35","doi-asserted-by":"publisher","first-page":"106473","DOI":"10.1016\/j.micpath.2023.106473","volume":"186","author":"H Barati","year":"2024","unstructured":"Barati, H., Fekrirad, Z., Jalali Nadoushan, M. & Rasooli, I. Anti-OmpA antibodies as potential inhibitors of Acinetobacter baumannii biofilm formation, adherence to, and proliferation in A549 human alveolar epithelial cells. Microb. Pathog. 186, 106473. https:\/\/doi.org\/10.1016\/j.micpath.2023.106473 (2024).","journal-title":"Microb. Pathog."},{"key":"79013_CR36","doi-asserted-by":"publisher","unstructured":"Barnowski, C., Kadzioch, N., Damm, D., Yan, H. & Temchura, V. Advantages and Limitations of Integrated Flagellin Adjuvants for HIV-Based nanoparticle B-Cell vaccines. Pharmaceutics. 11 https:\/\/doi.org\/10.3390\/pharmaceutics11050204 (2019).","DOI":"10.3390\/pharmaceutics11050204"},{"key":"79013_CR37","doi-asserted-by":"publisher","first-page":"1303446","DOI":"10.3389\/fimmu.2023.1303446","volume":"14","author":"JS Bolton","year":"2023","unstructured":"Bolton, J. S., MacGill, R. S., Locke, E., Regules, J. A. & Bergmann-Leitner, E. S. Novel antibody competition binding assay identifies distinct serological profiles associated with protection. Front. Immunol. 14, 1303446. https:\/\/doi.org\/10.3389\/fimmu.2023.1303446 (2023).","journal-title":"Front. Immunol."},{"key":"79013_CR38","doi-asserted-by":"publisher","first-page":"15480","DOI":"10.1038\/ncomms15480","volume":"8","author":"MP Cabral","year":"2017","unstructured":"Cabral, M. P. et al. Design of live attenuated bacterial vaccines based on D-glutamate auxotrophy. Nat. Commun. 8, 15480. https:\/\/doi.org\/10.1038\/ncomms15480 (2017).","journal-title":"Nat. Commun."},{"key":"79013_CR39","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.vaccine.2014.02.083","volume":"33","author":"R KuoLee","year":"2015","unstructured":"KuoLee, R. et al. Intranasal immunization protects against Acinetobacter baumannii-associated pneumonia in mice. Vaccine. 33, 260\u2013267. https:\/\/doi.org\/10.1016\/j.vaccine.2014.02.083 (2015).","journal-title":"Vaccine"},{"key":"79013_CR40","doi-asserted-by":"publisher","first-page":"e0016221","DOI":"10.1128\/IAI.00162-21","volume":"89","author":"TB Nielsen","year":"2021","unstructured":"Nielsen, T. B. et al. Monoclonal antibody therapy against Acinetobacter baumannii. Infect. Immun. 89, e0016221. https:\/\/doi.org\/10.1128\/IAI.00162-21 (2021).","journal-title":"Infect. Immun."},{"key":"79013_CR41","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1128\/IAI.06096-11","volume":"80","author":"LV Bentancor","year":"2012","unstructured":"Bentancor, L. V. et al. Evaluation of the trimeric autotransporter ata as a vaccine candidate against Acinetobacter baumannii infections. Infect. Immun. 80, 3381\u20133388. https:\/\/https:\/\/doi.org\/10.1128%2FIAI.06096-11 (2012).","journal-title":"Infect. Immun."},{"key":"79013_CR42","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1002\/jcp.30683","volume":"237","author":"V Kaushik","year":"2022","unstructured":"Kaushik, V., Tiwari, M., Joshi, R. & Tiwari, V. Therapeutic strategies against potential antibiofilm targets of multidrug-resistant Acinetobacter baumannii. J. Cell. Physiol. 237, 2045\u20132063. https:\/\/doi.org\/10.1002\/jcp.30683 (2022).","journal-title":"J. Cell. Physiol."},{"key":"79013_CR43","doi-asserted-by":"publisher","first-page":"705533","DOI":"10.3389\/fimmu.2021.705533","volume":"12","author":"G Kamuyu","year":"2021","unstructured":"Kamuyu, G. et al. Sequential vaccination with Heterologous Acinetobacter baumannii strains induces broadly reactive antibody responses. Front. Immunol. 12, 705533. https:\/\/doi.org\/10.3389\/fimmu.2021.705533 (2021).","journal-title":"Front. Immunol."},{"key":"79013_CR44","doi-asserted-by":"publisher","unstructured":"Jeffreys, S. et al. Insights into Acinetobacter baumannii protective immunity. Front. Immunol. 13 https:\/\/doi.org\/10.3389\/fimmu.2022.1070424 (2022).","DOI":"10.3389\/fimmu.2022.1070424"},{"key":"79013_CR45","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41577-019-0244-2","volume":"20","author":"M Akkaya","year":"2020","unstructured":"Akkaya, M., Kwak, K. & Pierce, S. K. B cell memory: building two walls of protection against pathogens. Nat. Rev. Immunol. 20, 229\u2013238. https:\/\/doi.org\/10.1038\/s41577-019-0244-2 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"79013_CR46","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3389\/fimmu.2017.00441","volume":"8","author":"MG Garcia-Patino","year":"2017","unstructured":"Garcia-Patino, M. G., Garcia-Contreras, R. & Licona-Limon, P. The Immune response against Acinetobacter baumannii, an Emerging Pathogen in Nosocomial infections. Front. Immunol. 8, 441. https:\/\/doi.org\/10.3389\/fimmu.2017.00441 (2017).","journal-title":"Front. Immunol."},{"key":"79013_CR47","doi-asserted-by":"publisher","first-page":"486","DOI":"10.3389\/fcimb.2020.00486","volume":"10","author":"W Chen","year":"2020","unstructured":"Chen, W. Host Innate Immune responses to Acinetobacter baumannii infection. Front. Cell. Infect. Microbiol. 10, 486. https:\/\/doi.org\/10.3389\/fcimb.2020.00486 (2020).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"79013_CR48","doi-asserted-by":"publisher","first-page":"103697","DOI":"10.1016\/j.micpath.2019.103697","volume":"138","author":"FB Hashemi","year":"2020","unstructured":"Hashemi, F. B. et al. A trivalent vaccine consisting of flagellin A\u2009+\u2009B and pilin protects against Pseudomonas aeruginosa infection in a murine burn model. Microb. Pathog. 138, 103697. https:\/\/doi.org\/10.1016\/j.micpath.2019.103697 (2020).","journal-title":"Microb. Pathog."},{"key":"79013_CR49","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1480-9222-15-9","volume":"15","author":"WG Luo","year":"2013","unstructured":"Luo, W. G., Liu, H. Z., Lin, W. H., Kabir, M. H. & Su, Y. Simultaneous splicing of multiple DNA fragments in one PCR reaction. Biol. Proced. Online. 15, 9. https:\/\/doi.org\/10.1186\/1480-9222-15-9 (2013).","journal-title":"Biol. Proced. Online"},{"key":"79013_CR50","doi-asserted-by":"publisher","first-page":"e114410","DOI":"10.1371\/journal.pone.0114410","volume":"9","author":"M Garcia-Quintanilla","year":"2014","unstructured":"Garcia-Quintanilla, M., Pulido, M. R., Pachon, J. & McConnell, M. J. Immunization with lipopolysaccharide-deficient whole cells provides protective immunity in an experimental mouse model of Acinetobacter baumannii infection. PLoS One. 9, e114410. https:\/\/doi.org\/10.1371\/journal.pone.0114410 (2014).","journal-title":"PLoS One"},{"key":"79013_CR51","doi-asserted-by":"publisher","first-page":"4503","DOI":"10.1038\/s41598-019-41171-8","volume":"9","author":"M Nikbakht","year":"2019","unstructured":"Nikbakht, M., Pakbin, B. & Nikbakht Brujeni, G. Evaluation of a new lymphocyte proliferation assay based on cyclic voltammetry; an alternative method. Sci. Rep. 9, 4503. https:\/\/doi.org\/10.1038\/s41598-019-41171-8 (2019).","journal-title":"Sci. Rep."},{"key":"79013_CR52","doi-asserted-by":"publisher","first-page":"e00023","DOI":"10.1128\/iai.00023-23","volume":"91","author":"V Solanki","year":"2023","unstructured":"Solanki, V., Tiwari, M. & Tiwari, V. Investigation of Peptidoglycan-Associated Lipoprotein of Acinetobacter baumannii and its Interaction with Fibronectin to find its therapeutic potential. Infect. Immun. 91, e00023\u2013e00023. https:\/\/doi.org\/10.1128\/iai.00023-23 (2023).","journal-title":"Infect. Immun."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79013-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79013-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79013-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T07:21:29Z","timestamp":1731655289000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79013-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,12]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["79013"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-79013-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4666148\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,12]]},"assertion":[{"value":"1 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27646"}}